发明申请
US20090081293A1 SUSTAINED RELEASE OF APO A-I MIMETIC PEPTIDES AND METHODS OF TREATMENT
有权
可持续发布的APO A-I型胶原蛋白和治疗方法
- 专利标题: SUSTAINED RELEASE OF APO A-I MIMETIC PEPTIDES AND METHODS OF TREATMENT
- 专利标题(中): 可持续发布的APO A-I型胶原蛋白和治疗方法
-
申请号: US11946028申请日: 2007-11-27
-
公开(公告)号: US20090081293A1公开(公告)日: 2009-03-26
- 发明人: Katsuyuki Murase , Jinping Wan , John Stankus , Dariush Davalian , Florian Ludwig
- 申请人: Katsuyuki Murase , Jinping Wan , John Stankus , Dariush Davalian , Florian Ludwig
- 主分类号: A61K9/10
- IPC分类号: A61K9/10 ; A61K31/661 ; A61K9/14 ; A61K38/10 ; A61K38/17 ; A61P3/00
摘要:
A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a composition including a sustained-release carrier and an apolipoprotein A-I (apo A-I) synthetic mimetic peptide into a wall of the blood vessel at the particular region or a perivascular site, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including an apolipoprotein A-I (apo A-I) synthetic peptide, or combination of an apo A-I synthetic mimetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of various apo A-I mimetic peptides, or endogenous apo A-I analogs, or a chimera of helix 1 and helix 9 of endogenous apo A-I.
公开/授权文献
信息查询